Blog - INTERNET MÉDICA

Choque Cardiogênico: Artigos de Revisão (Cardiogenic Shock: Reviews)

Por Paulo Leite 11/01/2021

■ Management of cardiogenic shock in a cardiac intensive care unit

Ju H. Kim, Anusha Sunkara, Sara Varnado

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): 36–42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137626/

■ A standardized and comprehensive approach to the management of cardiogenic chock – state-of-the-art review

B N Tehrani, A G Truesdell, M A Psotka et al

JACC: Heart Failure 2020, vol 8 (11): 879-891

https://www.jacc.org/doi/10.1016/j.jchf.2020.09.005?_ga=2.193241133.186653816.1610192384-1854695012.1600193052

■ Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study

Benedikt Schrage, Peter Moritz Becher, Alexander Bernhardt et al

Circulation. 2020 Dec 1; 142(22): 2095–2106

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688081/

■ ¨Therapeutics advances in the management of cardiogenic shock¨

O Chioncel, S P Collins, A P Ambrosy et al

Am J Ther. 2019 Mar-Apr; 26(2): e234–e247.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404765/

■ Pathophysiology and advanced hemodynamics assessment of cardiogenic shock

Michael I. Brener, Hannah R. Rosenblum, Daniel Burkhoff

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): 7–15.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137617/

■ Cardiogenic shock in the setting of acute myocardial infarction

Navin K. Kapur, Katherine L. Thayer, Elric Zweck

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): 16–21.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137623/

■ Cardiogenic shock in patients with advanced chronic heart failure

Cesar Y. Guerrero-Miranda, Shelley A. Hall

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): 22–26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137620/

■ Acute mechanical circulatory support for cardiogenic shock

Kartik S. Telukuntla, Jerry D. Estep

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): 27–35

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137625/

■ Physiological concepts of cardiogenic shock using pressure-volume loop simulations: a case-based review

Benjamin C. Salgado, Arvind Bhimaraj

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): 43–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137624/

■ Systems of care in cardiogenic shock

Maria M. Patarroyo Aponte, Carlos Manrique, Biswajit Kar

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): 50–56.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137632/

■ Cardiogenic shock in perioperative and intraoperative settings: a team approach

Faisal Masud, Gaurav Gheewala, Martin Giesecke, EE Suarez, Iqbal Ratnani

Methodist Debakey Cardiovasc J. 2020 Jan-Mar; 16(1): e1–e7

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137622/

■ Haemodynamic efficacy of microaxial left ventricular assist device in cardiogenic shock: a systematic review and meta-analysis

I. M. van Dort, K. R. A. H. Peij, O. C. Manintveld, et al

Neth Heart J. 2020 Apr; 28(4): 179–189

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113339/

■ Choque Cardiogênico: Casos Clínicos (Cardiogenic Shock: Case Reports

Arquivos Blog Internet Médica – abril 2020

https://internetmedica.com.br/choque-cardiogenico-clinicos-online-cardiogenic-shock-case-reports/

■ Balão intra-aórtico no choque cardiogênico: o estado da arte

P G Thomaz, L A Moura Júnior, G Muramoto, R S Assad

Rev Col Bras Cir 2017, vol 44 (1)

https://www.scielo.br/scielo.php?pid=S0100-69912017000100102&script=sci_arttext&tlng=pt (portuguese)

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912017000100102&lng=en&nrm=iso&tlng=en (English)

■ Choque cardiogénico – fármacos inotrópicos e vasopressores

J Amado, P Gago, W Santos et al

Rev Port Cardiol 2016, vol 35: 681-695

https://www.revportcardiol.org/pt-choque-cardiogenico-farmacos-inotropicos-articulo-S0870255116301974

■ Oxigenação por membrana extracorpórea: revisão da literatura

Chaves, Renato Carneiro de Freitas et al.

Rev. bras. ter. intensiva, Set 2019, vol.31, no.3, p.410-424

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-507X2019000300410&lng=en&nrm=iso

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Hipertensão Arterial: Perguntas & Respostas (Arterial Hypertension: Questions & Answers) 2021

Por Paulo Leite 10/01/2021

■ Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic?

Luciano F. Drager, Andrea Pio-Abreu, Renato D. Lopes, Luiz A. Bortolotto

Curr Hypertens Rep. 2020; 22(6): 43

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292934/

■ COVID-19 and arterial hypertension: Hypothesis or evidence?

M Tadic, C Cuspidi, G Grassi

The Journal of Clinical Hypertensionn 2020, vol 22 (7): 1120-1126

https://onlinelibrary.wiley.com/doi/10.1111/jch.13925

■ COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?

M Tadic, C Cuspidi

The Journal of Clinical Hypertension 2020, vol 22 (11): 1984-1986

https://onlinelibrary.wiley.com/doi/10.1111/jch.14045

■ Isolate nocturnal hypertension: What do we know and what can we do?

Marijana Tadic, Cesare Cuspidi, Guido Grassi, Giuseppe Mancia

Integr Blood Press Control. 2020; 13: 63–69

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183347/

■ To whom recommend intensive treatment for hypertension?

Massimo Volpe, Giovanna Gallo

Eur Heart J Suppl. 2020 Jun; 22(Suppl E): E167–E17

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270960/

■ Is resistant hypertension an independent predictor of all-cause mortality in individuals type 2 diabetes? A prospective cohort study

Anna Solini, Giuseppe Penno, Emanuela Orsi, et al

for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group

BMC Med. 2019; 17: 83

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482506/

■ Resistant hypertension: Where are we now and where do we go from here?

Mansur K Pathan, Debbie L Cohen

Integr Blood Press Control. 2020; 13: 83–93

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415451/

■ Afternoon blood pressure increase on home blood pressure measurement: a forgotten entity?

S Taguchi, K Tamura,

The Journal of Clinical Hypertension 2020, vol 22 (12): 2202-2203

https://onlinelibrary.wiley.com/doi/10.1111/jch.14078

■ Should elevated blood pressure be treated with antihypertensive drug therapy?

W S Aronow,

The Journal of Clinical Hypertensionn 2020, vol 22 (9): 1635-1637

https://onlinelibrary.wiley.com/doi/10.1111/jch.13981

■ Redefining diuretics use in hypertension: why select a thiazide-like diuretic?

Michel Burnier, George Bakris, Bryan Williams

J Hypertens. 2019 Aug; 37(8): 1574–1586.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615933/

■ Does arterial stiffness reflect cardiovascular risk in the very elderly?

H Tomiyama

The Journal of Clinical Hypertension 2020, vol 22 (12): 1216-1217

https://onlinelibrary.wiley.com/doi/10.1111/jch.13892

■ Is the association between sleep apnea and left ventricular hypertrophy obesity-independent?

C Cuspid, M Tadic, C Sala, G Grassi

The Journal of Clinical Hypertension 2020, vol 22 (7): 1282-1283

https://onlinelibrary.wiley.com/doi/10.1111/jch.13908

■ Does chronic kidney disease predict stroke risk independent of blood pressure? A systematic review and meta-regression

Dearbhla M. Kelly, Peter M. Rothwell

Stroke. 2019 Nov; 50(11): 3085–3092.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824504/

■ Wrist devices with both accuracy and feasibility, new option to measure nocturnal blood pressure?

R Heo, J Shin

The Journal of Clinical Hypertension 2020, vol 22 (6): 979-980

https://onlinelibrary.wiley.com/doi/10.1111/jch.13862

■ Did the 2017 ACC/AHA blood pressure guideline get it wrong in reducing the diastolic threshold to define hypertension from 90 to 80 mmHg?

B P McGrath, J W McEvoy

The Journal of Clinical Hypertension 2020, vol 22 (7): 1200-1201

https://onlinelibrary.wiley.com/doi/10.1111/jch.13899

■ Neprilysin: a potential therapeutic target of arterial hypertension?

Juan Salazar, Joselyn Rojas-Quintero, Clímaco Cano et al

Curr Cardiol Rev. 2019 Feb; 16(1): 25–35.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062041/